美国 · SEC FORM 4
IOVANCE BIOTHERAPEUTICS, INC.
IOVA · Nasdaq · CIK 0001425205 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
34 同一窗口内观察到的 Form 4 交易行
0 sales · 34 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-06-05 · Kirby Daniel Gordon · $55.2K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Vogt Frederick GInterim CEO & General Counsel
○○○○○○○○
Puri Raj K.Chief Regulatory Officer
○○○○○○○○
BILINSKY IGORChief Operating Officer
○○○○○○○○
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
○○○○
Kirby Daniel GordonChief Commercial Officer
○○○○
Roche Corleen M.Chief Financial Officer
○○
● 买入▼ 卖出○ 其他
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-06-05 · Kirby Daniel Gordon.
近期 Form 4 活动
0买入
0卖出
68其他 Form 4 交易行
31SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他34 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 64,827,030
- 上期报告
- 87,127,871
- 日均成交量
- 22,908,160
- 回补天数
- 2.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-06-05 | Kirby Daniel Gordon | 买入 (P) | Common Stock | 30,000 | USD 1.84 | USD 55,200 | SEC 申报 ↗ |
| 2025-05-23 | Puri Raj K. | 买入 (P) | Common Stock | 5,600 | USD 1.74 | USD 9,744 | SEC 申报 ↗ |
| 2025-05-14 | Vogt Frederick G | 买入 (P) | Common Stock | 25,000 | USD 1.69 | USD 42,250 | SEC 申报 ↗ |
| 2024-02-20 | Rothbaum Wayne P. | 买入 (P) | Common Stock | 5,000,000 | USD 9.15 | USD 45,750,000 | SEC 申报 ↗ |
| 2024-02-20 | MCPEAK MERRILL A | 买入 (P) | Common Stock | 250,000 | USD 9.15 | USD 2,287,500 | SEC 申报 ↗ |
| 2024-02-20 | Dukes Iain D. | 买入 (P) | Common Stock | 32,000 | USD 9.15 | USD 292,800 | SEC 申报 ↗ |
| 2023-09-18 | MCPEAK MERRILL A | 买入 (P) | Common Stock | 10,000 | USD 5.56 | USD 55,600 | SEC 申报 ↗ |
| 2023-09-15 | Rothbaum Wayne P. | 买入 (P) | Common Stock | 5,000,000 | USD 5.30 | USD 26,500,000 | SEC 申报 ↗ |
| 2022-12-21 | MCPEAK MERRILL A | 买入 (P) | Common Stock | 10,000 | USD 6.15 | USD 61,500 | SEC 申报 ↗ |
| 2022-12-02 | Rothbaum Wayne P. | 买入 (P) | Common Stock | 10,000,000 | USD 6.50 | USD 65,000,000 | SEC 申报 ↗ |
| 2022-11-29 | MCPEAK MERRILL A | 买入 (P) | Common Stock | 10,000 | USD 6.31 | USD 63,100 | SEC 申报 ↗ |
| 2022-11-28 | Vogt Frederick G | 买入 (P) | Common Stock | 1,000 | USD 5.98 | USD 5,980 | SEC 申报 ↗ |
| 2022-11-28 | MCPEAK MERRILL A | 买入 (P) | Common Stock | 10,000 | USD 6.18 | USD 61,800 | SEC 申报 ↗ |
| 2022-11-23 | Dukes Iain D. | 买入 (P) | Common Stock | 10,000 | USD 6.10 | USD 61,000 | SEC 申报 ↗ |
| 2022-06-01 | Vogt Frederick G | 买入 (P) | Common Stock | 1,000 | USD 6.44 | USD 6,440 | SEC 申报 ↗ |
Form 4 申报证据
68 transaction lines in the latest 365-day window; 230 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Vogt Frederick G | 期权行权／转换 (M) | Common Stock | 15,626 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-08 | Vogt Frederick G | 代扣税 (F) | Common Stock | 6,638 | USD 8.70 | USD 57,751 | SEC 申报 ↗ |
| 2026-09-08 | Puri Raj K. | 期权行权／转换 (M) | Common Stock | 9,766 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Vogt Frederick G | 期权行权／转换 (M) | Common Stock | 15,626 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-08 | Vogt Frederick G | 代扣税 (F) | Common Stock | 6,638 | USD 8.70 | USD 57,751 | SEC 申报 ↗ |
| 2026-09-08 | Puri Raj K. | 期权行权／转换 (M) | Common Stock | 9,766 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-08 | Puri Raj K. | 代扣税 (F) | Common Stock | 4,478 | USD 8.70 | USD 38,959 | SEC 申报 ↗ |
| 2026-09-08 | BILINSKY IGOR | 期权行权／转换 (M) | Common Stock | 7,813 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-08 | BILINSKY IGOR | 代扣税 (F) | Common Stock | 3,976 | USD 8.70 | USD 34,591 | SEC 申报 ↗ |
| 2026-09-01 | Vogt Frederick G | 期权行权／转换 (M) | Common Stock | 41,669 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Vogt Frederick G | 代扣税 (F) | Common Stock | 17,702 | USD 8.28 | USD 146,573 | SEC 申报 ↗ |
| 2026-09-01 | Puri Raj K. | 期权行权／转换 (M) | Common Stock | 5,470 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Puri Raj K. | 代扣税 (F) | Common Stock | 2,508 | USD 8.28 | USD 20,766 | SEC 申报 ↗ |
| 2026-09-01 | BILINSKY IGOR | 期权行权／转换 (M) | Common Stock | 8,789 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | BILINSKY IGOR | 代扣税 (F) | Common Stock | 4,472 | USD 8.28 | USD 37,028 | SEC 申报 ↗ |
| 2026-08-10 | Kirby Daniel Gordon | 期权行权／转换 (M) | Common Stock | 10,001 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-10 | Kirby Daniel Gordon | 代扣税 (F) | Common Stock | 2,436 | USD 6.40 | USD 15,590 | SEC 申报 ↗ |
| 2026-08-06 | Roche Corleen M. | 期权行权／转换 (M) | Common Stock | 49,995 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-06 | Roche Corleen M. | 代扣税 (F) | Common Stock | 21,238 | USD 6.21 | USD 131,888 | SEC 申报 ↗ |
| 2026-06-05 | Vogt Frederick G | 期权行权／转换 (M) | Common Stock | 15,625 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Vogt Frederick G | 代扣税 (F) | Common Stock | 6,638 | USD 4.23 | USD 28,079 | SEC 申报 ↗ |
| 2026-06-05 | Puri Raj K. | 期权行权／转换 (M) | Common Stock | 9,766 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Puri Raj K. | 代扣税 (F) | Common Stock | 3,843 | USD 4.23 | USD 16,256 | SEC 申报 ↗ |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | 期权行权／转换 (M) | Common Stock | 7,813 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | 代扣税 (F) | Common Stock | 3,976 | USD 4.23 | USD 16,818 | SEC 申报 ↗ |
| 2026-06-05 | BILINSKY IGOR | 期权行权／转换 (M) | Common Stock | 7,813 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | BILINSKY IGOR | 代扣税 (F) | Common Stock | 3,976 | USD 4.23 | USD 16,818 | SEC 申报 ↗ |
| 2026-06-01 | Vogt Frederick G | 期权行权／转换 (M) | Common Stock | 41,668 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Vogt Frederick G | 代扣税 (F) | Common Stock | 17,701 | USD 3.96 | USD 70,096 | SEC 申报 ↗ |
| 2026-06-01 | Puri Raj K. | 期权行权／转换 (M) | Common Stock | 5,469 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Puri Raj K. | 代扣税 (F) | Common Stock | 2,508 | USD 3.96 | USD 9,932 | SEC 申报 ↗ |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | 期权行权／转换 (M) | Common Stock | 8,790 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | 代扣税 (F) | Common Stock | 4,473 | USD 3.96 | USD 17,713 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | IOVA |
| CIK | 0001425205 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 230 transaction lines from 2020-01-02 to 2026-09-08 22 P purchase lines · 1 S sale lines · 207 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.